Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
| TNFRⅡ fusion protein（biosimilar） | Fusion/Recombination protein | Immunological disease | Rheumatoid Arthritis,Psoriasis,Ankylosing Spondylitis | NDA/BLA | Global (except China) |
Immobilized Human TNF-alpha Protein, His Tag (Cat. No. TNA-H5228) at 5 μg/mL (100 μL/well) can bind Biotinylated Human TNFR2 Protein, Fc,Avitag (Cat. No. TN2-H82F3) with a linear range of 0.01-0.313 μg/mL (QC tested).
The purity of Biotinylated Mouse TNFR2 Protein, His,Avitag (Cat. No. TN2-M82E3) is more than 90% and the molecular weight of this protein is around 40-55 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant human type II tumor necrosis factor receptor-antibody fusion protein(Hisun Biological) | Approved | Hisun Biopharmaceutical Co Ltd | Mainland China | Psoriasis; Arthritis, Rheumatoid; Spondylitis, Ankylosing | Hisun Biopharmaceutical Co Ltd | 2015-04-09 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| LBL-019 | LBL-019 | Phase 2 Clinical | Nanjing WeiLibo biological Technology Co Ltd | Neoplasms | Details |
| BI-1910 | BI-1910 | Phase 2 Clinical | Bioinvent International Ab | Solid tumours; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular | Details |
| BITR-2101 | BITR-2101; BIR-2101; BITT2101; BITT-2101 | Phase 1 Clinical | Boston Immune Technologies & Therapeutics | Infections; Lymphoma, T-Cell, Peripheral; Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous | Details |
| NBL-020 | Phase 1 Clinical | Shanghai Xinshi Biological Medicine Co Ltd | Solid tumours; Neoplasms | Details | |
| BC-011 | BC-011 | Phase 1 Clinical | Dragonboat Biopharmaceutical | Solid tumours | Details |
| SIM1811-03 | SIM1811-03; SIM0235; SIM-235 | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd | Solid tumours; Neoplasms; Lymphoma, T-Cell, Cutaneous | Details |
| HFB-200301 | HFB-2003; HFB-200301 | Phase 1 Clinical | HiFiBiO Therapeutics | Solid tumours; Skin Melanoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Neoplasms; Mesothelioma; Sarcoma; Testicular Neoplasms; Germinoma; Uterine Cervical Neoplasms; Neoplasm Metastasis; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.
A-Z
